These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6968781)

  • 1. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans.
    Kishimoto S; Tomino S; Mitsuya H; Fujiwara H; Tsuda H
    J Immunol; 1980 Nov; 125(5):2347-52. PubMed ID: 6968781
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis.
    Volkman DJ; Allyn SP; Fauci AS
    J Immunol; 1982 Jul; 129(1):107-12. PubMed ID: 6177745
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid.
    Stevens RH; Saxon A
    J Immunol; 1979 Feb; 122(2):592-8. PubMed ID: 310845
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A restricted component of T cell help in pokeweed mitogen-stimulated humans peripheral blood cell cultures.
    Macy E; Stevens RH
    J Immunol; 1980 Feb; 124(2):752-9. PubMed ID: 6965390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.
    Stevens RH; Macy E; Morrow C; Saxon A
    J Immunol; 1979 Jun; 122(6):2498-504. PubMed ID: 312871
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired generation of spontaneous and mitogen-reactive antitetanus toxoid antibody-producing B cells following repetitive in vivo booster immunization.
    Saxon A; Tamaroff MA; Morrow C; Stevens RH
    Cell Immunol; 1981 Mar; 59(1):82-96. PubMed ID: 6971181
    [No Abstract]   [Full Text] [Related]  

  • 8. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK; Munro AJ
    Clin Exp Immunol; 1981 Oct; 46(1):171-7. PubMed ID: 6978212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid.
    Geha RS
    Clin Immunol Immunopathol; 1981 May; 19(2):196-205. PubMed ID: 6971719
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization.
    Brogan MD; Shanahan F; Oliver M; Stevens RH; Targan SR
    J Clin Lab Immunol; 1987 Oct; 24(2):69-74. PubMed ID: 3437440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.
    North ME; Brenner MK
    Immunology; 1983 Jan; 48(1):157-63. PubMed ID: 6600229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses.
    Nies K; Boyer R; Stevens R; Louie J
    Arthritis Rheum; 1980 Dec; 23(12):1343-50. PubMed ID: 7006611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity.
    Thiele CJ; Morrow CD; Stevens RH
    J Immunol; 1981 Mar; 126(3):1146-53. PubMed ID: 6970218
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective regulation of the immune response to tetanus toxoid in Hashimoto's disease.
    Fawcett J; Hutton C; Mclachlan SM; Clark F; Rees Smith B
    Immunology; 1984 Jul; 52(3):525-8. PubMed ID: 6378767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers.
    Biasutti C; Moraes-Pinto MI; Segurado AC
    Vaccine; 2008 Jun; 26(23):2808-10. PubMed ID: 18455282
    [No Abstract]   [Full Text] [Related]  

  • 18. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans.
    Kishimoto S; Tomino S; Mitsuya H; Nishimura H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):1-10. PubMed ID: 6217937
    [No Abstract]   [Full Text] [Related]  

  • 19. The regulatory roles of T4 and T8 subsets in tetanus toxoid-induced in vitro immunoglobulin production.
    Orcutt-Thordarson N; Lum LG
    Cell Immunol; 1983 Nov; 82(1):184-95. PubMed ID: 6227396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells.
    Thiele CJ; Stevens RH
    J Clin Immunol; 1981 Jul; 1(3):174-80. PubMed ID: 6801082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.